PARIS - ExonHit Therapeutics SA and BioMérieux extended and expanded their research collaboration for developing new blood-based diagnostics for the early detection of cancers. (BioWorld International)
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)
